British researchers have halted trials of the AstraZeneca COVID-19 vaccine on children — as European health officials on Wednesday expressed growing confidence that it is tied to blood clots. Oxford University, which developed the drug along with AstraZeneca, confirmed late Tuesday that it was halting the pioneering trials that involved children as young as 6.